OTC Markets Group Welcomes ReGen III Corp. to OTCQX
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Mark Redcliffe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Algernon Pharmaceuticals Inc said that it had included nicotinate and pamoate as novel salt forms of DMT as part of its intellectual property patent...
Algernon Pharmaceuticals Inc said that it had included nicotinate and pamoate as novel salt forms of DMT as part of its intellectual property patent...
Vancouver, British Columbia--(Newsfile Corp. - April 19, 2022) - ReGen III Corp. (TSXV: GIII) (OTCQB: ISRJF) (FSE: PN4) ("ReGen III" or the "Company") is pleased to announce the appointment of Kimberly
Vancouver, British Columbia--(Newsfile Corp. - April 11, 2022) - Further to its news release dated April 8, 2022, ReGen III Corp. (TSXV: GIII) (OTCQB: ISRJF) (FSE: PN4) ("ReGen III" or the "Company")